PE-22-28
$49.95
- Buy 5+ of each and save 5%
- Buy 10+ of each and save 8%
- Product is sold in powder form, needs reconstitution before use. Please read more on our FAQ page.
PE-22-28 is an experimental synthetic neuropeptide studied for its potential interactions with TREK-1 potassium channels, neuronal signaling, neuroplasticity, and mood-related biological pathways. This spadin-derived peptide is of interest in preclinical neuroscience and neuropharmacology research.
For laboratory research use only. Not for human or veterinary use.
SHARE:
SHARE:
- Products sold on our website are designed for in vitro testing and lab experimentation exclusively.
- All the products you see on the website are being sold in a lyophilized powder state (freeze-dried), in a sealed sterile vial; and should be reconstituted.
- The product’s label clearly states the amount of product a vial contains; some products are offered in different variations.
- The products we are selling come in a sealed vial but require additional lab equipment for proper testing.
AVAILABILITY:
- Ships today if you order and pay by 12 PM CST
- Some product may take up to 72 hours to ship
- Backordered items will ship in 3-5 days
Product Name: PE-22-28
Category: Research Peptides
Form: Lyophilized Powder
Research Classification: Experimental Neuropeptide
Product Description
PE-22-28 is a synthetic peptide derived from a region of the naturally occurring protein spadin, which is associated with neurobiological signaling and potassium channel regulation. This experimental peptide has attracted scientific interest for its potential involvement in neurological function, mood-related pathways, and neuroplasticity. PE-22-28 is primarily investigated for its interactions with the TREK-1 potassium channel, a member of the two-pore-domain potassium channel family involved in regulating neuronal excitability. Preclinical research has explored spadin-related peptides for their potential antidepressant-like activity, making PE-22-28 an emerging subject of interest in neuroscience and neuropharmacology.Key Research Applications
- Neuroplasticity Research: Investigated in relation to neuronal adaptation and signaling pathways associated with brain function.
- Mood Regulation Studies: Explored in preclinical models involving depression-related biological mechanisms.
- TREK-1 Channel Research: Studied for potential interactions with potassium channels involved in neuronal excitability.
- Neuropharmacology: Investigated as part of research into experimental peptide-based approaches to neurological signaling.
- Neuronal Signaling: Relevant to studies examining the relationship between ion channel activity and neurological function.
Product Highlights
- Synthetic experimental neuropeptide
- Derived from spadin-related peptide research
- Associated with TREK-1 potassium channel investigations
- Studied in preclinical neuroscience research
- Supplied in lyophilized powder form
- Intended for controlled laboratory research
Storage & Handling
Store according to manufacturer-provided specifications. Protect from excessive heat, moisture, and direct sunlight. Follow validated laboratory protocols for handling, reconstitution, and storage.Research Disclaimer
For laboratory research use only. Not intended for human or veterinary consumption, injection, or therapeutic use. PE-22-28 is an experimental research compound. Its safety, effectiveness, and appropriate dosing in humans have not been established. It is not FDA-approved for treating depression, anxiety, or any other medical condition.
